Suppression of CDK2 expression by siRNA induces cell cycle arrest and cell proliferation inhibition in human cancer cells

키워드

참고문헌 (39)

1. Nurse, P., "Cyclin dependent kinases and cell cycle control (nobel lecture)", Chembiochem., 3, pp.596~603 (2002)
2. Murray, A. W., "Recycling the Cell Cycle: Cyclins Revisited", Cell, 116, pp.221~334 (2004)
3. Gong, L., "Adenovirus-mediated expression of both antisense ornithine decarboxylase and S-adenosylmethionine decarboxylase induces G1 arrest in HT-29 Cells", J. Biochem. Mol. Biol., 39, pp.730~736 (2006)
4. Larochelle, S., "Requirements for Cdk7 in the assembly of Cdk1", cyclin B and activation of cdk2 revealed by chemical genetics in human cells, 2007, pp.25, 839~850
5. Wandl, S., "Is olomoucine, a weak cdk2 inhibitor, able to induce apoptosis in cancer cells?", Ann. N Y Acad. Sci., 1171, pp.242~249 (2009)
6. Du, J., "Critical role of cdk2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF", Cancer Cell, 6, pp.565~576 (2004)
7. Narayanan, R., "Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A", cdk2 as a progesterone receptor coactivator, 2005, pp.25, 264~277
8. Jablonska, B., "cdk2 is critical for proliferation and self-renewal of neural progenitor cells in the adult subventricular zone", J. Cell Biol., 179, pp.1231~1245 (2007)
9. Li, X., "Role of cdk2 in the sequential phosphorylation", activation of C, Proc. Natl. Acad. Sci. U.S.A., pp.2007, 통권 : 104[DOI]
10. Neganova, I., "Expression and functional analysis of G1 to S regulatory components reveals an important role for cdk2 in cell cycle regulation in human embryonic stem cells", Oncogene, 28, pp.20~30 (2009)
11. Nakano, T., "Current advancement in radiation therapy for uterine cervical cancer", J. Radiat. Res. (Tokyo), 51, pp.1~8 (2010)
12. Nakano, T., "Long-term results of highdose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix", Cancer, 103, pp.92~101 (2005)
13. Whelan, J., "The role of interferons in the treatment of osteosarcoma", Pediatr Blood Cancer, 54, pp.350~354 (2010)
14. Müller, C. R., "Interferon-alpha as the only adjuvant treatment in high-grade osteosarcoma: long term results of the Karolinska Hospital series", Acta Oncol., 44, pp.475~480 (2005)
15. Fire, A., "Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans", Nature, 391, pp.806~811 (1998)
16. Tuschl, T., "Targeted mRNA degradation by double-stranded RNA in vitro", Genes Dev., 13, pp.3191~3197 (1999)
17. Fjose, A., "RNA interference: mechanisms and applications", Biotechnol. Annu. Rev., 7, pp.31~57 (2001)
18. Bantounas, I., "RNA interference and the use of small interfering RNA to study gene function in mammalian systems", J. Mol. Endocrinol., 33, pp.545~557 (2004)
19. Martin, S. E., "Applications of RNA interference in mammalian systems", Annu. Rev. Genomics Hum. Genet., 8, pp.81~108 (2007)
20. Kim, D., "RNAi mechanisms and applications", Biotechniques, 44, pp.613~616 (2008)
21. Elbashir, S. M., "Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells", Nature, 411, pp.494~498 (2001)
22. Kim, J., "A simple and economical short-oligonucleotidebased approach to shRNA generation", J. Biochem. Mol. Biol., 39, pp.329~334 (2006)
23. McIntyre, G. J., "Design and cloning strategies for constructing shRNA expression vectors", BMC Biotechnol, 6, pp.1~8 (2006)
24. Whitehead, K. A., "Knocking down barriers:advances in siRNA delivery", Nat. Rev. Drug. Discov., 8, pp.129~138 (2009)
25. Sui, G., "A DNA vector-based RNAi technology to suppress gene expression in mammalian cells", Proc. Natl. Acad. Sci. U.S.A., 통권 : 99, pp.5515~5520 (2002)
26. Ammosova, T., "RNA interference directed to cdk2 inhibits HIV-1 transcription", Virology, 341, pp.171~178 (2005)
27. Lai, S. R., "RNA interference using a plasmid construct expressing short-hairpin RNA", Methods Mol. Biol., 405, pp.31~37 (2007)
28. Park, K. J., "Current concepts in cervical pathology", Arch.Pathol. Lab. Med., 133, pp.729~738 (2009)
29. Schwartz, L. A., "Cervical cancer: disease prevention and informational support", Can. Oncol. Nurs. J., 19, pp.6~9 (2009)
30. Messerschmitt, P. J., "Osteosarcoma", J. Am. Acad. Orthop. Surg., 17, pp.515~527 (2009)
31. Li, K., "Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma", Cancer Res., 63, pp.3593~3597 (2003)
32. Wu, H., "Small interfering RNA-induced suppression of MDR1 (P-glycoprotein) restores sensitivity to multidrug-resistant cancer cells", Cancer Res., 63, pp.1515~1519 (2003)
33. Xu, X. M., "RNA-mediated gene silencing of the RON receptor tyrosine kinase alters oncogenic phenotypes of human colorectalcarcinoma cells", Oncogene, 23, pp.8464~8474 (2004)
34. Lapteva, N., "CXCR4 knokdown by small interfering RNA abrogates breast tumor growth in vivo", Cancer Gene Ther., 12, pp.84~89 (2005)
35. Reynolds, A., "Rational siRNA design for RNA interference", Nat. Biotechnol., 22, pp.326~330 (2004)
36. Elbashir, S. M., "RNA interference is mediated by 21- and 22-nucleotide RNAs", Genes Dev., 15, pp.188~200 (2001)
37. Zeng, Y., "RNA interference in human cells is restricted to the cytoplasm", RNA, 8, pp.855~860 (2002)
38. Kawasaki, H., "Short hairpin type of dsRNAs that are controlled by tRNAVal promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells", Nucleic Acids Res., 31, pp.700~707 (2003)
39. Shukla, V., "RNAi-based conditional geneknockdown in mice using a U6 promoter driven vector", Int. J. Biol. Sci., 3, pp.91~99 (2007)

관련 논문AI추천